Equity Overview
Price & Market Data
Price: $2.84
Daily Change: +$0.03 / 1.06%
Range: $2.78 - $2.89
Market Cap: $301,119,520
Volume: 420,654
Performance Metrics
1 Week: 11.37%
1 Month: -8.39%
3 Months: -40.34%
6 Months: -24.47%
1 Year: -28.28%
YTD: -31.73%
Company Details
Employees: 114
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.